Ignite Creation Date:
2024-07-17 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465069
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-13
Brief Title:
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Solid Tumor |
| Recurrent Solid Tumor |
| Advanced Solid Tumor |
| Urinary Bladder Neoplasm |
| Triple Negative Breast Cancer |
| Non-small Cell Lung Cancer |
| Esophageal Cancer |
| Pancreatic Cancer |
| Ovarian Cancer |
| Cervical Cancer |
| Head and Neck Squamous Cell Carcinoma |
| Prostate Cancer |
| Renal Pelvis Cancer |
| Bladder Cancer |
Keywords:
| Name | View |
|---|---|
| Bladder Cancer | View |
| Bladder Neoplasm | View |
| Bladder Urothelial Carcinoma | View |
| Urinary Bladder Cancer | View |
| Urinary Tract Cancer | View |
| Urothelial Neoplasms | View |
| Renal Pelvis Cancer | View |
| Ureter Cancer | View |
| Nectin-4 | View |
| Antibody Drug Conjugate ADC | View |
| Triple Negative Breast Cancer TNBC | View |
| Non-small Cell Lung Cancer NSCLC | View |
| Head and Neck Squamous Cell Carcinoma HNSCC | View |